[1] |
WANG Zezhou , ZHANG Yang , MO Miao , YUAN Jing , ZHOU Changming , SHEN Jie , FENG Xiaoshuang , WU Haoxuan , LI Hang , YE Ting , HU Hong , CHEN Haiquan , ZHENG Ying .
Distribution of metastatic sites and survival analysis of patients with non-metastatic lung cancer at initial diagnosis based on hospital registration
[J]. China Oncology, 2021, 31(9): 775-782.
|
[2] |
LU Li, LU Renquan, SUN Jiajun, LU Ning, GUO Lin.
The application of serum N-MID in auxiliary diagnosis and therapeutic effect monitoring of bone metastasis in patients with primary lung cancer
[J]. China Oncology, 2021, 31(9): 838-844.
|
[3] |
ZHANG Xuecheng , GUAN Xiaohui .
Circ_0007142 accelerates epithelial-mesenchymal transition and invasion of gastric cancer cells through sponging miR-647 and regulating CCR8 gene
[J]. China Oncology, 2021, 31(8): 714-724.
|
[4] |
ZHU Yihui, LI Ting, HU Xichun.
Clinical research progress and prospect of trastuzumab deruxtecan
[J]. China Oncology, 2021, 31(8): 754-761.
|
[5] |
LI Haizhou , ZHANG Yanwei , XU Yingjie , YANG Men , ZHANG Lei , HAN Jingjun .
miR-933 inhibits proliferation, migration and invasion of lung cancer cell lines by regulation of KLF6 gene
[J]. China Oncology, 2021, 31(7): 581-588.
|
[6] |
YANG Jia , LIU Shuyuan , WANG Yingying , LI Yingfu , MA Qianli , LI Yu , WANG Yongrong , LI Chuanyin , TAN Fang .
The association of polymorphisms in TNF-α gene with non-small cell lung cancer in Han population of Yunnan Province
[J]. China Oncology, 2021, 31(7): 616-628.
|
[7] |
XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia.
The advances in immunotherapy biomarkers of small cell lung cancer
[J]. China Oncology, 2021, 31(7): 635-639.
|
[8] |
CAO Dalong, ZHU Wenkai, SHI Guohai, ZHANG Hailiang, WANG Ziliang, YE Dingwei.
The influence of PRUNE2 gene point mutation on proliferation, apoptosis, invasion and migration of prostate cancer DU145 cells
[J]. China Oncology, 2021, 31(6): 441-446.
|
[9] |
HU Yaqiong , BAI Jun , CHEN Lin , CHEN Xinlu , ZHANG Liping , ZHOU Dandan , WANG Yu , YIN Chonggao , LI Hongli , LIU Yuqing .
miR-625-5p promotes proliferation and invasion of lung adenocarcinoma by targeting PRKACA
[J]. China Oncology, 2021, 31(6): 447-454.
|
[10] |
CHEN Jie, WANG Yan, ZHANG Weimin, ZHAO Di, ZHANG Lingyuan, ZHAN Qimin.
Hypoxia induces expression of IL-7 in esophageal squamous cell carcinoma to promote tumor progression
[J]. China Oncology, 2021, 31(5): 361-367.
|
[11] |
LIU Min , CHEN Tianliang , GUO Juan , YI Xue , GAO Hongquan , WU Jiacui , WANG Yuxiao .
Protein kinase Cβ Ⅱ promotes invasion of hepatocellular carcinoma by modulating autocrine of IL-6
[J]. China Oncology, 2021, 31(4): 268-276.
|
[12] |
QIAO Tingting , GE Shujing , LUO Yuan , LU Chengrong , DUAN Lianning .
Mechanism of inhibition of epithelial-to-mesenchymal transition by phosphorylated H2AX in lung cancer cells
[J]. China Oncology, 2021, 31(4): 277-284.
|
[13] |
MU Lina , SU Jia , YU Shunzhang , NIU Rungui , HAN Xiaoyou , LIU Li , SHI Jianping , ZHANG Zuofeng .
The control of lung cancer relating to quitting active smoking and secondary smoking: a case-control study of lung cancer in Taiyuan
[J]. China Oncology, 2021, 31(4): 335-343.
|
[14] |
WANG Chunjian , NIE Gang , MAO Yan .
The role of TRIP6 in breast cancer and its mechanism
[J]. China Oncology, 2021, 31(3): 161-169.
|
[15] |
YI Weili , ZHAO Wencheng , HUANG Dongning , QIN Li , WU Xintian , ZHOU Fei , WU Fengying .
Analysis of immune-related adverse events and its correlation with efficacy of anti-PD-1 monotherapy in advanced non-small cell lung cancer
[J]. China Oncology, 2021, 31(3): 203-211.
|